Co-Valtin is a combination drug of amlodipine and valsartan presented by Mohammed Moshiur Rahaman of ACME Laboratories Ltd. It is available in 5/80 mg and 5/160 mg doses for 9 and 16 taka respectively. The drug treats hypertension and can be increased to a maximum dose of 10/320 mg after 1-2 weeks. It targets cardiologists, endocrinologists, neurologists, medicine specialists and nephrologists. The valsartan and amlodipine market was 15.5 crore in size in 2Q 2014 with 46% growth, led by generic companies Incepta, Popular and Square.